Health technology firm Senseonics rang the opening bell at the New York Stock Exchange Wednesday.
The company, whose shares trade under the ticker "SENS," marked the start of trading to celebrate the company's official listing on the exchange last Friday, according to the New York Stock Exchange.
Senseonics designs and develops glucose monitoring devices for patients with diabetes. Its first glucose monitoring system consists of an implanted sensor linked to a mobile app for continuous glucose monitoring for up to 90 days, according to a company press release.
NYSE MKT, formerly known as the American Stock Exchange, was acquired in 2008 by NYSE Euronext, the parent company of the New York Stock Exchange.